Business Strategy

Explore how using support tools can prevent treatment overutilization.

Mental health advocate Patrick J. Kennedy talks to Managed Healthcare Executive about reform, mental health equity, and how payers can help integrate care in mental health.

A Trump administration is expected to have far-reaching impacts on healthcare. Here are nine changes to keep on your radar.

Medicare plans must understand the impact of CMS rule change to be prepared for risk adjustment in 2017. Here are 10 tips to better manage the risk adjustment process.

Study: ACOs can be part of the structure to improve outcomes in children with medical complexity.

Here’s what managed healthcare executives should keep an eye on moving into the new year.

Humana and Oak Street Health share the challenges and opportunities of moving away from the fee-for-service model to value-based care.

As 2016 comes to a close, how do healthcare leaders feel about the state of the industry? Here’s your chance to find out.

The 21st Century Cures Act, a landmark medical research bill, offers healthcare executives a promising future.

Industry leaders share their sources of inspiration.

Pharmaceutical manufacturer relationships and next-gen value based contracts are primed to accelerate value-derivation from your drug spend.

Experts share their ideas on how President-elect Trump could change the single largest source of insurance in the country.

In the aftermath of the presidential election, health policy experts have less to go on than they have after any election in memory.

Results from Managed Healthcare Executive’s annual State of the Industry Survey reveal which issues will hit managed healthcare hardest in 2017.

President-elect Trump named Tom Price and Seema Verma to lead HHS and CMS, respectively. Here’s what you should know about them.

As development of molecular biomarkers hastens, administrators, clinicians and regulators are working to organize and define biomarkers’ appropriate roles in clinical care-and discussing how to efficiently share the massive amounts of genomic data that will result.

Hospitals and health systems that treat some of the country’s most vulnerable populations face complex challenges when working to improve population health.

None of Trump’s plans, such as repealing parts of Obamacare or expanding HSAs, will rein in the rising cost of healthcare.

Plans and PBMs are finding new ways to rein in pharmacy costs.

Telephonic and personalized diabetes self-education programs which fit into patient’s busy lives will make a greater impact than in-person classes only.

Joint ventures are gaining steam as health plans and providers look for new ways to work together.

Two experts discuss top-of-mind women’s healthcare issues in managed care.

Does your analytics team have what it takes? Experts share their top recommendations.

The AMA and medical schools across the country are placing new emphasis on population health management and value-based care.

Here’s how one non-profit health plan harnessed the power of medical and pharmacy data to rein in drug costs.